USFDA extends review of Bristol Myers’ cancer therapy acquired in Celgene deal
The company said it had submitted additional information on the therapy known as liso-cel, which was considered a major amendment…
Recover your password.
A password will be e-mailed to you.
Recover your password.
A password will be e-mailed to you.